Our results showed that UCP2 expression was downregulated in malignant tissues of patients with COPD and NSCLC compared with that in patients with NSCLC alone, suggesting a role of COPD-related hypoxia in regulating UCP2 expression (Figure 2A). This evidence concerns the gene UCP2 and chronic obstructive pulmonary disease.